Saxena, Ashish

Publications

Sort by

Co-Author Network

selected publications

Advancements in small cell lung cancer. Seminars in cancer biology. 2023 Review GET IT
Combining radiation therapy with immune checkpoint blockade for the treatment of small cell lung cancer. Seminars in cancer biology. 2023 Review GET IT
Ischemic stroke with cancer: Hematologic and embolic biomarkers and clinical outcomes. Journal of thrombosis and haemostasis : JTH. 2022 Academic Article GET IT
Times cited: 3
Lung Cancer Stage Shift as a Result of COVID-19 Lockdowns in New York City, a Brief Report. Clinical lung cancer. 2021 Academic Article GET IT
Times cited: 9
Mechanisms of Ischemic Stroke in Patients with Cancer: A Prospective Study. Annals of neurology. 2021 Academic Article GET IT
Times cited: 20
Impact of Use of Antibiotics on Response to Immune Checkpoint Inhibitors and Tumor Microenvironment. American journal of clinical oncology. 2021 Academic Article GET IT
Times cited: 13
Neoadjuvant durvalumab with or without stereotactic body radiotherapy in patients with early-stage non-small-cell lung cancer: a single-centre, randomised phase 2 trial. The Lancet. Oncology. 2021 Academic Article GET IT
Times cited: 126
Extracellular vesicles from human airway basal cells respond to cigarette smoke extract and affect vascular endothelial cells. Scientific reports. 2021 Academic Article GET IT
Times cited: 9
Radiation Therapy for Small-Cell Lung Cancer: ASCO Guideline Endorsement of an ASTRO Guideline. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2021 Academic Article GET IT
Times cited: 24
Development of the Oncolo-GIST ("Giving Information Strategically & Transparently") Intervention Manual for Oncologist Skills Training in Advanced Cancer Prognostic Information Communication. Journal of pain and symptom management. 2020 Academic Article GET IT
Times cited: 4
Identification of a Microsatellite Stable, EGFR-Mutant Lung Adenocarcinoma Developing in a Patient With Lynch Syndrome. JCO precision oncology. 2020 Academic Article GET IT
Times cited: 1
JSCO-ESMO-ASCO-JSMO-TOS: international expert consensus recommendations for tumour-agnostic treatments in patients with solid tumours with microsatellite instability or NTRK fusions. Annals of oncology : official journal of the European Society for Medical Oncology. 2020 Academic Article GET IT
Times cited: 66
MET Alterations Are a Recurring and Actionable Resistance Mechanism in ALK-Positive Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2020 Academic Article GET IT
Times cited: 99
Cancer-Related Ischemic Stroke Has a Distinct Blood mRNA Expression Profile. Stroke. 2019 Academic Article GET IT
Times cited: 9
The lung microenvironment: an important regulator of tumour growth and metastasis. Nature reviews. Cancer. 2019 Review GET IT
Times cited: 496
Extracellular vesicles in DLBCL provide abundant clues to aberrant transcriptional programming and genomic alterations. Blood. 2018 Academic Article GET IT
Times cited: 21
Brigatinib in Patients With Alectinib-Refractory ALK-Positive NSCLC. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2018 Academic Article GET IT
Times cited: 55
Molecular Testing for Stage IV Non-Small Cell Lung Cancer Patients With Targetable Mutations Following Disease Progression. Archives of pathology & laboratory medicine. 2018 Comment GET IT
Atezolizumab-Induced New Onset Diabetes Mellitus With Ketoacidosis. American journal of therapeutics. 2018 Letter GET IT
Times cited: 6
BO-1055, a novel DNA cross-linking agent with remarkable low myelotoxicity shows potent activity in sarcoma models. Oncotarget. 2016 Academic Article GET IT
Times cited: 6
Treatment of recurrent and platinum-refractory stage IV non-small cell lung cancer with nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as a single agent. Medical oncology (Northwood, London, England). 2016 Academic Article GET IT
Times cited: 9
Therapeutic Effects of Repurposed Therapies in Non-Small Cell Lung Cancer: What Is Old Is New Again. The oncologist. 2015 Review GET IT
Times cited: 29
Double trouble: a case of concurrent de novo T790M and L858R EGFR mutations in treatment-naive advanced non-small-cell lung cancer. 2014 GET IT
Times cited: 3
Efficacy and safety of antiretrovirals in HIV-infected patients with cancer. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2014 Academic Article GET IT
Times cited: 43
Systemic therapy for small cell lung cancer. Journal of the National Comprehensive Cancer Network : JNCCN. 2013 Review GET IT
Times cited: 15
Bortezomib-induced thrombotic thrombocytopaenic purpura. BMJ case reports. 2012 Academic Article GET IT
Times cited: 22
Surgery for early-stage small cell lung cancer. Journal of the National Comprehensive Cancer Network : JNCCN. 2011 Review GET IT
Times cited: 32
Intratracheally administered 5-azacytidine is effective against orthotopic human lung cancer xenograft models and devoid of important systemic toxicity. Clinical lung cancer. 2010 Academic Article GET IT
Times cited: 13
Structure-function analysis of the human TFIIB-related factor II protein reveals an essential role for the C-terminal domain in RNA polymerase III transcription. Molecular and cellular biology. 2005 Academic Article GET IT
Times cited: 21

more ...

less ...

Background

education and training

M.D., State University of New York at Stony Brook, School of Medicine 2006
Ph.D., State University of New York at Stony Brook 2004
B.A., New York University 1997

Contact

full name

Ashish Saxena

primary email

ahs9018@med.cornell.edu

webpage

Clinical Profile

VIVO Weill Cornell Medical College

Ashish Saxena Assistant Professor of Medicine

Publications

selected publications

Background

education and training

Contact

full name

primary email

webpage

Phone

Publications

selected publications

Background

education and training

Contact

full name

primary email

webpage